Annual reminder needed for mammography

July 22, 2004

NEW YORK CITY - Healthcare providers need to take the initiative and encourage all women over age 40 to have annual mammograms, according to Stephen A. Feig, M.D., who helped develop the 2003 American Cancer Society guidelines on breast cancer screenings.

"If dentists can send out postcards for teeth cleanings, women should also receive reminders for annual screening mammography," asked Dr. Feig, professor of radiology at Mount Sinai School of Medicine in New York. "We need to get the word out to more women."

Dr. Feig spoke today at a Radiological Society of North America (RSNA) media briefing on women's breast health.

A Swedish study showed death rates from breast cancer have dropped by as much as 50 percent because of mammography, yet one in three American women over 40 has not had a mammogram during the last two years.

Dr. Feig said fear, misinformation and controversy surrounding mammography are discouraging women from making annual appointments. He is calling on primary caregivers, women's health specialists, radiologists and oncologists to assist in a massive education effort.

"The mammogram is the best screening tool available today for detecting breast cancer early, when it is most treatable," Dr. Feig said. "We offer women much better mammography today than we did for their mothers and grandmothers."

Dr. Feig also encouraged women to continue having a yearly mammogram regardless of their advancing age. The American Cancer Society guidelines have no upper age limit for mammography. Dr. Feig said that as long as a woman is in reasonably good health and would benefit from early cancer detection, she should continue to be screened with mammography.

"The breast cancers we are finding today are much smaller than they were years ago," Dr. Feig said. "This means that they are easier to cure and there is a greater choice of therapeutic options for women, including breast conservation."

Dr. Feig pointed to some other signs that improvements are being made in mammography: "Our challenge now is to meet an increasing demand for mammography as the population of women over the age of 40 increases," Dr. Feig said.
-end-
RSNA is an association of more than 35,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill. (http://www.rsna.org)

Radiological Society of North America

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.